Current Technologies for Sub-Micrometer and Micrometer Particle Analysis for Biologics
Posted on September 10, 2025
Andrea Hawe, Chief Scientific Officer
Daniel Weinbuch, Business Development Manager
Coriolis Pharma Research
Introduction Analyzing and controlling the particle content in biopharmaceutical drug products is a challenge scientists must face throughout a product’s life cycle starting at early drug research, during drug product development, manufacturing and storage. Particles can hereby originate from the ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















